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Because of the complex nature of Parkinson’s disease, a wide variety of health professionals are involved in care. Stepwise, we
have addressed the challenges in the provision of multidisciplinary care for this patient group. As a starting point, we have
gained detailed insight into the current delivery of allied healthcare, as well as the barriers and facilitators for optimal care.
To overcome the identiﬁed barriers, a tertiary referral centre was founded; evidence-based guidelines were developed and cost-
eﬀectively implemented within regional community networks of speciﬁcally trained allied health professionals (the ParkinsonNet
concept).WeincreasinglyuseICTtobindtheseprofessionalnetworkstogetherandalsotoempowerandengagepatientsinmaking
decisions about their health. This comprehensive approach is likely to be feasible for other countries as well, so we currently
collaborate in a European collaboration to improve community care for persons with Parkinson’s disease.
1.Background
The number of patients with Parkinson’s disease (PD) and
related forms of parkinsonism is increasing in all ageing
societies [1]. In Western Europe’s ﬁve, and the world’s 10
most populous nations, the number of individuals with PD
over the age of 50 was between 4.1 and 4.6 million in 2005;
these numbers will be doubled by 2030 [1]. Likewise, the
costs related to PD care will increase dramatically. PD is
a very complex disorder, characterised by a wide array of
both motor and nonmotor problems for which medical care
alone is insuﬃcient [2–6]. As a reﬂection of this complexity,
no less than 18 diﬀerent disciplines (e.g., physiotherapy and
psychology) may be involved in PD care [7–9]. However,
patients often have no access to the allied healthcare required
[10]. Moreover, the involvement of various disciplines
requires close collaboration and integration of medical
and nonmedical care. Great challenges remain in the way
multidisciplinary care is best realized for Parkinson patients.
But, where to start? The purpose of this paper is to share the
various steps we have taken (Figure 1), as they are likely to be
feasible for application in other countries.
2. Stepwise Improvement of Community
Health Care
Step1(gaininginsightintocurrentcare). Detailedinsightinto
the current provision of allied healthcare, as well as barriers
and facilitators for optimal care, was lacking. As a ﬁrst
step, we therefore aimed to evaluate current care. Surveys
involving more than 500 PD patients and 300 allied health
professionals were used to gain this insight [11, 12]. The
results revealed that on average therapists treated as few as
three individual PD patients a year. Therapists also reported
that they had only limited expertise in treating PD. A major
barrier for improvement was the absence of guidelines to2 Parkinson’s Disease
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Figure 1: Steps of the Dutch model to improve community healthcare for Parkinson’s disease.
support these therapists in providing optimal treatment.
Most patients were referred by their neurologist. However,
referring physicians had no information about the beneﬁts
of, for example, physiotherapy in PD, and were unable
to ﬁnd therapists with PD-speciﬁc interest or expertise.
Finally, therapists of diﬀerent disciplines (e.g., speech and
language therapy, occupational therapy, and physiotherapy)
were often unaware of each other’s treatment possibilities.
Moreover, communication about a common patient (e.g.,
on treatment goals and timing of interventions) was very
poor. As trends have been found towards positive eﬀects
of integrated care programs in the chronically ill [13] this
neededtobeimproved.Therefore,ournextstepwastocreate
a regional Parkinson, multidisciplinary expert centre.
Step 2 (creation of a regional expert centre). In order to
oﬀer expert care to PD patients and their carers, a regional
Parkinson’s expert centre was initiated. The centre serves as
a tertiary referral centre for a large catchment area, by
oﬀering critical revision of the diagnosis (if needed sup-
ported by ancillary investigations), recommendations with
respect to drug treatment and stereotactic neurosurgery, and
individually tailored multidisciplinary treatment advice. The
centre also initiates and coordinates clinical trials and dis-
seminates the newly acquired knowledge. The centre is part
of the neurology department of one of the eight Dutch
university medical centres. Several comparable initiatives
have meanwhile arisen across the country.
Step 3 (development of evidence-based guidelines). Next, we
started to develop evidence-based guidelines for allied
healthcare. As physiotherapy is the most applied allied
healthcare discipline in PD care, we ﬁrst developed a guide-
line that targeted physiotherapy for PD. Conform interna-
tional standards for guideline development, practice recom-
mendations were developed based on the results of a sys-
tematic literature review, clinical expertise, and patient
values. The recommendations were graded according to
the level of evidence available [14]. The guideline was
authorized and distributed by our national professional
organisation for physiotherapy, the Royal Dutch Society for
Physical Therapy (KNGF). Likewise, guidelines for speechParkinson’s Disease 3
and language therapy and for occupational therapy were
developed, authorized, and distributed [15]. For other disci-
plines,forexample,dieticians,thedevelopmentofguidelines
has recently started. The guidelines provide decision support
for everyday clinical practice.
3.ParkinsonNet
Asdisseminationdoesnotautomaticallyleadtoimplementa-
tion, we developed a multifaceted implementation strategy:
ParkinsonNet. ParkinsonNet not only aims to implement
the guidelines, but also to reorganise allied healthcare to
increase the patient volume of therapists, make expert
healthcare professionals visible to other professionals as well
as to patients, and support communication amongst health
c a r ep r o f e s s i o n a l si n v o l v e di nP Dc a r ea sw e l la sb e t w e e n
professionals and patients. To set up a ParkinsonNet, ﬁrst a
region needed to be deﬁned.
Step 4 (deﬁnition of a parkinsonNet region). Members of the
ParkinsonNet team (at the regional expert centre) together
with the coordinating neurologist of a general hospital de-
ﬁned the catchment area for which the ParkinsonNet needed
to be developed. Within this geographic area, a local com-
munity of allied health professionals with Parkinson-speciﬁc
expertise was created. The key points in this process
were selection, training, communication, and transparency
(Figure 1,s t e p s5t o8 ) .
Step 5 (selection of dedicated professionals). To succeed in in-
creasing the patient volume, a relatively small number of
therapists were selected for each regional ParkinsonNet. To
allow the networks to evolve slowly, the Dutch networks
were set up with a maximum of one physiotherapist for
every 20,000 residents in the speciﬁc region, and one speech
and occupational therapist for every 40,000 residents. These
numbers were based on the preferred patient volume as
reported by therapists (i.e., 15), the estimated number of PD
patients in the Netherlands, the current referral pattern of
physicians (more patients are referred to physiotherapy in
comparison with occupational therapy or speech and lan-
guage therapy), and the number of residents in the prede-
ﬁned region.
For selection, all allied health professionals in a speciﬁc
region were informed about the beneﬁts, requirements, and
costs for participation. In all regions, the numbers of phys-
iotherapists interested in participation exceeded the required
number, making a selection required. Professionals working
in the same neighbourhood were therefore asked to arrange
self-selection. Only when this was not successful, the Par-
kinsonNet team made the selection based on motivation,
bio sketch and current function in regional PD care. In the
selection process we tried to reach a good geographical
dispersion in the region. This, as an evaluation under Dutch
PD patients and allied health professionals, revealed that
they both were prepared to travel up to 15 minutes.
Step 6 (training based on guidelines). All allied health pro-
fessionals selected for a future network participated in
the same 3-day (for the ﬁrst networks this was a 4-day),
interactive course. Here they were trained to treat PD
patients according to the evidence-based guidelines. The
program entailed both mono- and multidisciplinary classes.
Participating neurologists and PD nurse specialists were
informed about the referral criteria and main treatment
options of the allied health professions included in their re-
gional ParkinsonNet. For physiotherapists, a guideline-based
electronic patient record was developed to further support
their clinical decision taking. During the course, physiother-
apists were trained to use this patient record.
Step 7 (supporting communication). Starting at the course,
networking was supported. For example, professionals from
a speciﬁc region shared a table during lunch and together
prepared and completed educational tasks during the course.
After the course, continuation of network meetings takes
place during three-monthly regional seminars and a yearly
ParkinsonNet congress (see Step 9). Concerning communi-
cation about common patients, the development of regional
communication plan was facilitated. In addition, a secured
web-based community is used to enhance communication,
both within the ParkinsonNet as with hospital professionals.
Step8(transparency). Patients,medicalandnonmedicalcare
professionals were informed about the ParkinsonNet. The
location of the specialized therapists is visualized by web-
based sources and printed folders. Moreover, structured and
preferred referral to ParkinsonNet therapists by neurologists
was supported by using standardized referral forms, includ-
ing objective referral criteria. So, participating therapist were
enabled to attract a large number of patients. A certiﬁcation
system, supported by professional societies, was developed
to guarantee the quality of therapy provided by health
professionals participating in these networks.
Step 9 (continuous education and exchange of knowledge).
Each regional ParkinsonNet organises, if needed with sup-
port by the ParkinsonNet team, three-monthly seminars to
for example, practice skills, discuss cases, and to enhance
(multidisciplinary) collaboration within the region. Every
year, the ParkinsonNet team organises a national Parkinson-
Net congress with national and international speakers and a
widevarietyofParkinson’srelatedworkshops(e.g.,oncogni-
tivefunctioning,sleep,nutrition,andexerciseandthebrain).
In addition, through a secured web-based community, up-
to-date information is shared by the ParkinsonNet team.
4. Scientiﬁc EvaluationParkinsonNet
In 2004, the ﬁrst, multidisciplinary ParkinsonNet was de-
signed and tested for its feasibility [17]. This ParkinsonNet
included neurologists, a PD nurse specialist, physiothera-
pists, occupational therapists, and speech and language ther-
apists. Given its feasibility and the enthusiasm of the par-
ticipants, a cluster-randomized trial was designed to further
evaluate ParkinsonNet. For feasibility purposes of the trial,
eight ParkinsonNets were developed which only included
the most used allied healthcare in PD, that is, physiotherapy.4 Parkinson’s Disease
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Figure 2: Coverage of ParkinsonNet throughout the Netherlands.
Theses clusters were compared with eight clusters where care
remained unchanged. The trial, in which 699 PD patients
participated, showed that the quality of care increased and
the volume of patients per therapist more than doubled
within as little as six months while considerably saving
costs [18]. In addition, evaluation of the connectedness of
healthcare professionals within the ParkinsonNet showed
thatespeciallytherapiststreatingmorethanninePDpatients
a year were associated with stronger connectedness with
other health professionals than those treating less than 10
PD patients a year. As connectedness between professionals
is known to inﬂuence clinical decision making and the
coordination of patient care [19], this knowledge is of high
importance to the size of future networks.
5. National Coverage ParkinsonNet
Supported by these positive results, ParkinsonNet was en-
dorsed by professional healthcare organizations and the
national patient society. In 2010 national coverage within the
Netherlands was achieved by 65 unique networks (Figure 2).
The size of the networks is related to the population density
of the speciﬁc regions. In addition to increase in number of
networks,manyadditionaldisciplineshavebeenaddedtothe
ParkinsonNet. Currently, throughout the Netherlands, 1885
care professionals are participating, amongst which 57 neu-
rologists, 107 PD nurse specialists, 809 physiotherapists, 317
occupational therapists, 318 speech and language therapists,
89 dieticians, 76 elderly care physicians, 62 psychologists, 31
social workers, and 4 sex therapists.
6.MultidisciplinaryGuidelines
In addition to the monodisciplinary guidelines, a multidisci-
plinary guideline has been developed in a joint collaboration
among professional organizations of 18 medical professions,
the patient society, and two national healthcare knowledge
and quality institutes [7]. The multidisciplinary guideline
includes recommendations not only for daily medical and
nonmedical practice, as an update of the NICE guidelines
[8], but also for network care. Speciﬁcally these recommen-
dations, concerning collaboration, expertise, communica-
tion,andﬁnanceswerelackingintheexistingguidelines[20],
even though they are of high importance. For example, in
outpatient neurology, dissatisfaction with communication is
related to noncompliance [21]. As part of the support for
collaboration, the guideline provides a detailed overview of
impairments, limitations, restrictions, and external factors
related to PD (Figure 3)[ 7]. For this overview the common
language of the International Classiﬁcation of Functioning,Parkinson’s Disease 5
Dysfunction of the basal ganglia, caused by degeneration of dopamine-producing cells in the substantia nigra (ICD-10: G20)  
Impairments in functions  Activity limitations and restrictions in
participation: 
b1: Mental functions
Dementia (b117)
Impairments in temperament and personality (b126)
Impairments in energy and drive functions, e.g. reduced motivation 
Sleep impairments (b134)
Reduced attention (b140)
Impairments in perceptual functions, e.g. reduced visuospatial 
perception and hallucinations∗
Impairments in higher level cognitive functions, e.g. in planning, 
decision-making and mental ﬂexibility (b164)
Impairments in mental functions of language, e.g. verbal 
perseveration (b167)
b2: Sensory functions and pain
Seeing impairments, e.g. visual acuity∗ (b210)
Dizziness∗ (b240)∗
Impairments in smell (b255)
Proprioceptive function (b260)
Tingling (b265)
(Central) pain (b280)
b3: Voice and speech functions (b3)
Reduced pitch and loudness of voice (b310)
Impaired articulation (including dysarthria) (b320)
Reduced ﬂuency of speech (b330)
b4: Functions of the cardiovascular and respiratory systems
Impairments in blood pressure (e.g. orthostatic hypotension∗)
(b420) 
Reduced exercise tolerance∗ (b455) 
b5: Functions of the digestive system
swallowing (b510) 
Constipation∗ (b525)
Reduced weight maintenance (b530)
b6: Genitourinary and reproductive functions
Impaired urination, e.g. (urge)incontinence∗ (b620)
Impaired sexual functions, e.g. impotence and increased sexual 
b7: Neuromusculoskeletal and movement-related functions
Reduced joint mobility∗ (b710)
Reduced muscle power∗ (b730)
Impaired muscle tone functions, e.g. rigidity  and dystonia (b735)
Reduced muscle endurance∗ (b740)
Impaired motor reﬂex functions (b750), e.g. simultaneous  
contraction of antagonists
Reduced postural responses (b755)
Reduced control of voluntary movements (b760), e.g. 
dysdiadochokinesia, reduced ‘’motor set’’ causing starting 
problems and reduced or absence of internal cues causing 
problems in automated, sequential movements
Impaired involuntary movement functions (b765), e.g. 
bradykinesia, (resting) temor and dyskinesia∗
Impairments in gait patterns, e.g. asymmetry, freezing, reduced 
step length, velocity, trunk rotation and arm swing (b770)
d1: Learning and applying knowledge, e.g.
acquiring skills (d155), writing (d170),
solving problems (d175) and making
decisions (d177)    
d2: General tasks and demands, e.g..
undertaking multiple tasks (d220), carrying
out daily routine (230), handling stress and
other psychological demands (d240)     
d3: Communication, e.g. speaking (d330), 
producing non-verbal messages (d335),
writing messages (d345)  
d4: Mobility, e.g. changing and maintaining
body position (d410–d429), carrying, moving 
and handling objects (d430–d449), walking
and moving (d450–d469), moving around
using transportation (d470–d489)   
d5: Self-care, e.g. washing oneself (d510),
toileting (d530), dressing (d540), eating
(d550) and drinking (d560)  
d6: Domestic life, e.g. preparing meals 
(d630) and doing housework (d640)
d7: Interpersonal interactions and
relationships , e.g. basic interpersonal
interactions (d710) and particular
interpersonal relationships with strangers,
formal persons, family and husband or wife 
(d730–d779)     
d8: Major life areas, e.g. education (d810–
839), work and employment (d840–d859)
and economic life (d860–d879)
d9: Community, social and civic life , e.g.
community life (d910), recreation and
leisure (d920), religion (d930) and political
life (d950)   
Environmental factors, e.g.: Personal factors, e.g.:
e1: Products en technology, e.g. assistive devices, design of homes and public buildings and ﬁnancial assets
e2: Natural environment and human-made changes to environment, e.g. population density, ﬂora, fauna, climate, light intensity 
e3: Support and relationships, e.g. with family, friends, colleagues, people in the authority and health professionals
e4: Attitudes, e.g. of people, social attitudes and norms 
e5: Services, systems and policies, e.g. housing, transportation, communication, social support, health services and education
Age and gender
Education
Experiences and preferences
Co-morbidity and coping skills
These are not ICF classiﬁed because of large 
social and cultural variances
On/oﬀ periods∗ 
interest∗ (b640)
and impulse control∗ (b130)
Impairments in emotion, e.g. anxiety
∗ (b152)
•
•
•
•
•
•
•
•
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•
•
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•
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b8:  Functions of the skin and related structures
Impairments in sweating and sebum production (b830)
Impaired sensations related to the skin (pins and needles) (b840)
(b156)
Impaired ingestion, e.g. drooling, vomiting∗ and impaired 
(b798)
Figure 3: ICF model for Parkinson’s disease. ICF: International Classiﬁcation of Functioning, Disability and Health; numbers, for example,
b770, refer to codes in the ICF Handbook [16].
Disability, and Health (ICF) was used [16]. So far, an ICF
for neurology combining three neurologic disorders was
available, but not for PD speciﬁc [22]. This PD-speciﬁc clas-
siﬁcation can further improve communication in relation to
patientfunctioningbetweenhealthcareworkers,researchers,
and social policy makers.
7. EmpoweringPatients
Traditionally, the relationship between patients and their
healthcare providers is fairly paternalistic, with healthcare
providers making decisions (with the best intentions) and
patients simply carrying out instructions. Some patients ap-
preciate this role. However, many patients wish to have more
control over their own care [23] and patient preferences
may diﬀer from what doctors focus on [24]. The guideline
supports patient empowerment, for example, by teaching
therapists how to get to the treatment goal in “partnership”
with the patient. This, however, will not be suﬃcient [25].
Increasingly, the Internet can provide solutions to support
patient empowerment [26]. To further support patients
within ParkinsonNet regions to participate in medical
decisions made about their health, we developed a web-
based “portal to empower patients.” The portal provides
patients with information necessary to make choices in their
own health care process. For example, this includes actual
and controlled information about all treatment options. In
addition, patients are enabled to easily ﬁnd a specialized
health care professional within their community, based on
transparentbackgroundinformation(e.g.,thenumberofPD
patients treated by a professional, or the education received
to increase Parkinson-speciﬁc knowledge and expertise).
Another tool for patients will be the opportunity to build
their own virtual network of care providers, supporting
information sharing and collaboration between all partici-
pants.
8. InternationalCollaboration
As described, one of our ﬁrst steps to improve PD care
was the development of an evidence-based physiotherapy
guideline [14]. An external quality evaluation of all Parkin-
son guidelines available worldwide, by the Dutch Institute
for Health Care Improvement (CBO), showed that this
guideline is one of the few which is of good quality [7].
In addition, to date, it is still unique in its ﬁeld. As a
consequence, internationally there is a lot of interest for
using the guideline. The Association for Physiotherapists in
Parkinson’s Disease Europe (APPDE; http://www.appde.eu/)
therefore endorses the guideline and its implementation.
Currently, we are updating the guideline, in a joint
collaboration among 19 European physiotherapy associa-
tions, members of the European Region of the World6 Parkinson’s Disease
Confederation for Physical Therapy (ER-WCPT). This will
lead to a ﬁrst European guideline for physiotherapy in Par-
kinson’s disease in 2012. As a ﬁrst step in the guideline de-
velopment, surveys have been set out Europe-wide (n =
10,000) to gain insight into current care, barriers met in
delivering this care, possibilities for improvements and to
identify those therapists interested to become members of
a PD expert’s network. Perhaps this is another ﬁrst step
towards improving community healthcare (Figure 1). The
results of the survey will be used to develop key questions
for the European guideline. In addition, the results will sup-
port the participating countries to further structure their
guideline implementation plans.
Atthesametime,possibilitiesforusingtheParkinsonNet
concept for implementation of the guideline are being ex-
plored in several European countries as well as in the Unit-
ed States. The approach seems applicable to other countries
with a similar population density and health care system
(e.g., compensation of physical therapy). Through these fu-
ture networks, also the guidelines for occupational ther-
apy and for into English in collaboration with the National
Parkinson Foundation (http://www.parkinson.org/), can be
implemented and thus leading to multidisciplinary Parkin-
s o n ’ sn e t w o r k si nm a n yc o u n t r i e s .
9. Conclusions
Given the complex nature of PD, many disciplines will be
involved in Parkinson care. Aiming for optimal Parkinson
care, in the Netherlands, care for persons with Parkinson’s
has been changed stepwise. The Dutch approach seems ap-
plicable to other countries, be it with adaptations based on
population density and health care organization.
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